Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Sci Rep ; 11(1): 5223, 2021 03 04.
Article in English | MEDLINE | ID: mdl-33664381

ABSTRACT

A novel patient cluster in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) may be identified in Japan. We performed multiple correspondence and cluster analysis regarding 427 clinically diagnosed AAV patients excluding eosinophilic granulomatosis with polyangiitis. Model 1 included the ANCA phenotype, items of the Birmingham Vasculitis Activity Score, and interstitial lung disease; model 2 included serum creatinine (s-Cr) and C-reactive protein (CRP) levels with model 1 components. In seven clusters determined in model 1, the ANCA-negative (n = 8) and proteinase 3-ANCA-positive (n = 41) groups emerged as two distinct clusters. The other five myeloperoxidase-ANCA-positive clusters were characterized by ear, nose, and throat (ENT) (n = 47); cutaneous (n = 36); renal (n = 256), non-renal (n = 33); and both ENT and cutaneous symptoms (n = 6). Four clusters in model 2 were characterized by myeloperoxidase-ANCA negativity (n = 42), without s-Cr elevation (< 1.3 mg/dL) (n = 157), s-Cr elevation (≥ 1.3 mg/dL) with high CRP (> 10 mg/dL) (n = 71), or s-Cr elevation (≥ 1.3 mg/dL) without high CRP (≤ 10 mg/dL) (n = 157). Overall, renal, and relapse-free survival rates were significantly different across the four clusters in model 2. ENT, cutaneous, and renal symptoms may be useful in characterization of Japanese AAV patients with myeloperoxidase-ANCA. The combination of s-Cr and CRP levels may be predictive of prognosis.


Subject(s)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/blood , Antibodies, Antineutrophil Cytoplasmic/blood , Kidney Diseases/epidemiology , Peroxidase/blood , Skin Abnormalities/epidemiology , Aged , Aged, 80 and over , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/classification , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/epidemiology , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/pathology , C-Reactive Protein/metabolism , Creatinine/blood , Disease-Free Survival , Female , Humans , Japan/epidemiology , Kidney Diseases/blood , Kidney Diseases/classification , Kidney Diseases/pathology , Male , Middle Aged , Phenotype , Skin Abnormalities/blood , Skin Abnormalities/classification , Skin Abnormalities/pathology
3.
Clin Genet ; 91(3): 411-425, 2017 03.
Article in English | MEDLINE | ID: mdl-27582382

ABSTRACT

The tenascin-X (TNX) deficient type Ehlers-Danlos syndrome (EDS) is similar to the classical type of EDS. Because of the limited awareness among geneticists and the challenge of the molecular analysis of the TNXB gene, the TNX-deficient type EDS is probably to be under diagnosed. We therefore performed an observational, cross-sectional study. History and physical examination were performed. Results of serum TNX measurements were collected and mutation analysis was performed by a combination of next-generation sequencing (NGS), Sanger sequencing and multiplex ligation-dependent probe amplification (MLPA). Included were 17 patients of 11 families with autosomal recessive inheritance and childhood onset. All patients had hyperextensible skin without atrophic scarring. Hypermobility of the joints was observed in 16 of 17 patients. Deformities of the hands and feet were observed frequently. TNX serum level was tested and absent in 11 patients (seven families). Genetic testing was performed in all families; 12 different mutations were detected, most of which are suspected to lead to non-sense mRNA mediated decay. In short, patients with the TNX-deficient type EDS typically have generalized joint hypermobility, skin hyperextensibility and easy bruising. In contrast to the classical type, the inheritance pattern is autosomal recessive and atrophic scarring is absent. Molecular analysis of TNXB in a diagnostic setting is challenging.


Subject(s)
Ehlers-Danlos Syndrome/genetics , Joint Instability/genetics , Skin Abnormalities/genetics , Tenascin/genetics , Adolescent , Adult , Aged , Child , Cross-Sectional Studies , Diagnosis, Differential , Ehlers-Danlos Syndrome/blood , Ehlers-Danlos Syndrome/physiopathology , Female , High-Throughput Nucleotide Sequencing , Humans , Joint Instability/blood , Joint Instability/physiopathology , Male , Middle Aged , Mutation , Skin Abnormalities/blood , Skin Abnormalities/physiopathology , Tenascin/blood , Young Adult
4.
Eur J Immunol ; 28(4): 1379-88, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9565378

ABSTRACT

The autosomal recessive mutation "flaky skin" (fsn) causes pleiotropic abnormalities in the immune and hematopoietic systems accompanied by pathologic changes in the skin. Homozygotes (fsn/fsn) showed increased size and histological alterations in the spleen and lymph nodes. Abnormalities in lymphoid architecture of the spleen in fsn/fsn mice were accompanied by marked increases in total numbers of B cells, macrophages, and immature erythroid cells. Splenic B cells displayed elevated MHC class II expression. Serum IgE levels were greater than 100 microg/ml by 10 weeks of age, representing > 7000-fold increase compared with normal littermates. This increased IgE level was associated with elevated IL-4 production by spleen cells and with increased amounts of serum IL-4. Serum IgM, IgG1, and IgG2b levels were also increased in fsn/fsn mice while IgG3 was decreased. Autoimmunity in fsn/fsn mice was evidenced by glomerulonephritis accompanied by immune complex deposition in the kidneys, increased serum blood urea nitrogen levels, and the presence of circulating anti-double-stranded DNA autoantibodies. Pathological changes in the skin of fsn/fsn mice were characterized by epidermal hyperplasia and mixed dermal inflammation. Increased numbers of mast cells were also observed in the dermis of the truncal skin as well as in the epithelial stomach. These marked immunological abnormalities suggest that the fsn locus encodes a major immunoregulatory molecule important in multiple immune and hematopoietic functions.


Subject(s)
Autoimmunity , Immunoglobulin E/blood , Lymphatic Diseases/genetics , Mast Cells/immunology , Mast Cells/pathology , Skin Abnormalities/immunology , Abnormalities, Multiple/blood , Abnormalities, Multiple/genetics , Abnormalities, Multiple/immunology , Animals , Immunoglobulin E/immunology , Interleukin-4/blood , Lymphatic Diseases/immunology , Mice , Mice, Mutant Strains , Skin Abnormalities/blood , Skin Abnormalities/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...